Doctors told not to prescribe key diabetes drugs to new patients amid supply crisis
The TGA says semaglutide will not be available until the end of March
The RACGP has told GPs not to start patients on semaglutide or dulaglutide amid an ongoing global supply shortage fuelled by off-label prescribing for weight loss.
It follows a new warning from the TGA late last week that semaglutide (Ozempic) will not be available in Australia from mid-November until the end of March next year.
